Bayer AG (BAYRY)
7.04
-0.02
(-0.21%)
USD |
OTCM |
Apr 18, 16:00
Bayer Total Assets (Quarterly): 128.51B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 128.51B |
| September 30, 2023 | 124.10B |
| June 30, 2023 | 132.22B |
| March 31, 2023 | 136.36B |
| December 31, 2022 | 133.92B |
| September 30, 2022 | 128.77B |
| June 30, 2022 | 134.54B |
| March 31, 2022 | 140.39B |
| December 31, 2021 | 136.14B |
| September 30, 2021 | 135.19B |
| June 30, 2021 | 136.17B |
| March 31, 2021 | 139.24B |
| December 31, 2020 | 143.66B |
| September 30, 2020 | 140.32B |
| June 30, 2020 | 139.08B |
| March 31, 2020 | 138.39B |
| December 31, 2019 | 141.34B |
| September 30, 2019 | 143.07B |
| June 30, 2019 | 145.97B |
| March 31, 2019 | 146.22B |
| December 31, 2018 | 144.87B |
| September 30, 2018 | 150.43B |
| June 30, 2018 | 157.86B |
| March 31, 2018 | 92.95B |
| December 31, 2017 | 90.08B |
| Date | Value |
|---|---|
| September 30, 2017 | 90.37B |
| June 30, 2017 | 94.54B |
| March 31, 2017 | 90.89B |
| December 31, 2016 | 86.94B |
| September 30, 2016 | 85.86B |
| June 30, 2016 | 83.95B |
| March 31, 2016 | 86.85B |
| December 31, 2015 | 80.81B |
| September 30, 2015 | 83.79B |
| June 30, 2015 | 84.82B |
| March 31, 2015 | 82.99B |
| December 31, 2014 | 85.41B |
| September 30, 2014 | 76.91B |
| June 30, 2014 | 74.95B |
| March 31, 2014 | 77.65B |
| December 31, 2013 | 70.86B |
| September 30, 2013 | 70.03B |
| June 30, 2013 | 69.29B |
| March 31, 2013 | 67.75B |
| December 31, 2012 | 67.87B |
| September 30, 2012 | 68.24B |
| June 30, 2012 | 65.11B |
| March 31, 2012 | 72.31B |
| December 31, 2011 | 68.35B |
| September 30, 2011 | 70.52B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
124.10B
Minimum
Sep 2023
145.97B
Maximum
Jun 2019
136.70B
Average
136.36B
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 33.08B |
| Affimed NV | 107.40M |
| InflaRx NV | 132.88M |
| MorphoSys AG | 2.240B |
| BioNTech SE | 25.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 91.95B |
| Shareholders Equity (Quarterly) | 36.40B |
| Debt to Equity Ratio | 1.264 |
| Current Ratio | 1.275 |
| Net Debt Paydown Yield | -25.38% |